AmerisourceBergen Corporation.

With a growing number of complex cell and gene therapies approved globally, mostly for rare disease populations, manufacturers are looking at how to make these products more accessible by delivering a

The US needs a more diversified pharmaceutical supply chain, but the transition may need to be more delicate than current policy proposals would suggest, FDA Commissioner Robert Califf said. Almost al

Medicare price negotiation for Part B oncology drugs will have ramifications across Medicare and commercial insurance markets because of the way that reimbursement works for physician-administered dru

Shanghai Henlius Biotech Co. Ltd. has announced the successful completion of a Phase I/II clinical trial to assess the safety and preliminary efficacy of HLX04-O (bevacizumab), a recombinant anti-VEG